What is he best known for?
The fields of study he is best known for:
- Surgery
- Internal medicine
- Pathology
Surgery, Arthroplasty, Pathology, Bone morphogenetic protein and Bone morphogenetic protein 2 are his primary areas of study.
Surgery is closely attributed to Anesthesia in his study.
His Arthroplasty study incorporates themes from Chemoprophylaxis, Randomized controlled trial and Etiology.
The various areas that Jay R. Lieberman examines in his Pathology study include Patella, Bone morphogenetic protein 7, Cartilage and Osteoblast.
His work carried out in the field of Bone morphogenetic protein brings together such families of science as Femur and Mesenchymal stem cell.
His Bone morphogenetic protein 2 research is multidisciplinary, relying on both Stromal cell, Molecular biology, Genetic enhancement, Cell biology and Bone morphogenetic protein 5.
His most cited work include:
- Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. (1077 citations)
- The role of growth factors in the repair of bone. Biology and clinical applications. (811 citations)
- Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. (560 citations)
What are the main themes of his work throughout his whole career to date?
Jay R. Lieberman mostly deals with Surgery, Arthroplasty, Pathology, Bone healing and Genetic enhancement.
His Surgery and Orthopedic surgery, Pulmonary embolism, Total hip arthroplasty, Complication and Femoral head investigations all form part of his Surgery research activities.
His research investigates the connection between Arthroplasty and topics such as Physical therapy that intersect with problems in Joint arthroplasty and Total knee arthroplasty.
His Pathology study combines topics from a wide range of disciplines, such as Bone metastasis, Prostate cancer and Noggin, Bone morphogenetic protein.
The Bone morphogenetic protein study combines topics in areas such as Bone morphogenetic protein 2 and Spinal fusion.
His Genetic enhancement research includes elements of Tissue engineering, Ex vivo, Bioinformatics, Viral vector and Bone regeneration.
He most often published in these fields:
- Surgery (39.86%)
- Arthroplasty (18.53%)
- Pathology (16.08%)
What were the highlights of his more recent work (between 2018-2021)?
- Arthroplasty (18.53%)
- Genetic enhancement (13.99%)
- Physical therapy (10.84%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Arthroplasty, Genetic enhancement, Physical therapy, Bone healing and Total hip arthroplasty.
His research integrates issues of Odds ratio, Orthopedic surgery, Depression and General surgery in his study of Arthroplasty.
His Genetic enhancement research includes themes of Tissue engineering, Ex vivo, Cancer research, Viral vector and Bone regeneration.
Jay R. Lieberman works mostly in the field of Cancer research, limiting it down to topics relating to Umbilical cord and, in certain cases, Bone morphogenetic protein 2.
Jay R. Lieberman interconnects Stem cell and Pathology in the investigation of issues within Bone healing.
His Pathology study integrates concerns from other disciplines, such as Adipose tissue and Growth factor.
Between 2018 and 2021, his most popular works were:
- Risk stratification in primary total joint arthroplasty: the current state of knowledge. (21 citations)
- Early Results From the American Joint Replacement Registry: A Comparison With Other National Registries (18 citations)
- Medicare Reimbursement for Hip and Knee Arthroplasty From 2000 to 2019: An Unsustainable Trend. (17 citations)
In his most recent research, the most cited papers focused on:
- Surgery
- Internal medicine
- Orthopedic surgery
His primary areas of study are Arthroplasty, Surgery, Total hip arthroplasty, Physical therapy and Bone morphogenetic protein 2.
In the field of Arthroplasty, his study on Total knee overlaps with subjects such as Joint replacement registry.
His research in Surgery intersects with topics in Meta-analysis and Confidence interval.
His study looks at the intersection of Total hip arthroplasty and topics like Current Procedural Terminology with Orthopedic surgery.
The concepts of his Physical therapy study are interwoven with issues in Total knee arthroplasty, Medicaid and Medicare reimbursement.
In his study, which falls under the umbrella issue of Bone morphogenetic protein 2, Bone healing is strongly linked to Genetic enhancement.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
